+关注
LKK123
暂无个人介绍
IP属地:海外
815
关注
19
粉丝
0
主题
0
勋章
主贴
热门
LKK123
2022-09-23
好
@问就是加仓up:写在腾讯股价创近四年新低之际
LKK123
2021-11-11
这篇文章不错,转发给大家看
@四叶草们:
$Bank of America(BAC)$
M
LKK123
2021-11-11
这篇文章不错,转发给大家看
@10f6ccb4:
$Bank of America(BAC)$
[微笑]
LKK123
2021-08-16
hi
抱歉,原内容已删除
LKK123
2021-08-14
hi
Tesla seeks to reduce board members’ terms, make other changes in October shareholder meeting
LKK123
2021-08-13
等等
抱歉,原内容已删除
LKK123
2021-08-12
hi
BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4090580149975460","uuid":"4090580149975460","gmtCreate":1627478738972,"gmtModify":1706620619446,"name":"LKK123","pinyin":"lkk123","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":19,"headSize":815,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.53%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"海外","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":661641403,"gmtCreate":1663913568603,"gmtModify":1663913571224,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"好","listText":"好","text":"好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/661641403","repostId":"661121977","repostType":1,"repost":{"id":661121977,"gmtCreate":1663773601200,"gmtModify":1663774713799,"author":{"id":"3548388348794551","authorId":"3548388348794551","name":"问就是加仓up","avatar":"https://static.tigerbbs.com/4e98ddf789d46c5627f944fc581c0fe9","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3548388348794551","authorIdStr":"3548388348794551"},"themes":[],"title":"写在腾讯股价创近四年新低之际","htmlText":"今天盘中腾讯股价再次跌2%,股价几乎创近4年新低,相比于之前跌破300港币无数人疾呼抄底,这次明显安静了很多,氛围感也没有了,毕竟上半年港股急跌以腾讯跌破300港币收尾。这次,又会怎么走? 本文仅为个人投资思考记录,不构成任何投资建议,格局不同,立场不同,仅供参考。 就在一年多以前,在全球牛市的衬托下,国内基金振臂高呼跨过香江争夺定价权,腾讯连续日内10%的涨幅拉升,股价一度接近750港币,当时的口号是1000港币不是梦,不是我在这瞎吹,我当时还买了800港币的涡轮,当时觉得突破1000不算啥事。随后没几天就开始掉转形式向下,开启了无限的下跌,绵延至今。从月线可以看出,这一路没有特别暴力的反弹。 目前腾讯股价的下跌主要几个原因,最最主要的其实是大股东的减持,港股的流动性虽然 很差,但是以腾讯的声望,还是有很多的资金在不断抄底,但是一旦有人开始稳定持续的减持,对股价的影响那就容易倾斜,在大股东减持之前,其实股价本就处于弱平衡之下,腾讯目前每天也是在稳定回购,回购金额约占当日成交金额的十分之一以下,目前无法看到大股东每日减持明细,因为每减持1%的股份才会发布一次减持公告,上次发布是9.8日的时候,当时持股降到了27.96%,下次公告是持股减持到27%以下的时候,即在减持9600w股,今天腾讯成交了1600w股,我没查到港股减持的规则,假设每天减持200w股,大约需要45多个交易日,上次大股东转入了1.9亿股,全部减持完大概需要100个交易日。 而且这是算术的角度看,从理性的角度看,大股东肯定想要卖个好价钱 ,不可能无脑卖出,所以股价跌得多了,卖出速度会变慢。这些股份大概率是要全部卖出的,基本上意味着未来大半年腾讯的股价基本上会承受非常大的压力,如果你不知道什么叫压力,最近一个月的走势就是压力。 大股东的抛售金额大概率是高于每天腾讯自身回购的金额,所以你可以将这个回购行为的价值","listText":"今天盘中腾讯股价再次跌2%,股价几乎创近4年新低,相比于之前跌破300港币无数人疾呼抄底,这次明显安静了很多,氛围感也没有了,毕竟上半年港股急跌以腾讯跌破300港币收尾。这次,又会怎么走? 本文仅为个人投资思考记录,不构成任何投资建议,格局不同,立场不同,仅供参考。 就在一年多以前,在全球牛市的衬托下,国内基金振臂高呼跨过香江争夺定价权,腾讯连续日内10%的涨幅拉升,股价一度接近750港币,当时的口号是1000港币不是梦,不是我在这瞎吹,我当时还买了800港币的涡轮,当时觉得突破1000不算啥事。随后没几天就开始掉转形式向下,开启了无限的下跌,绵延至今。从月线可以看出,这一路没有特别暴力的反弹。 目前腾讯股价的下跌主要几个原因,最最主要的其实是大股东的减持,港股的流动性虽然 很差,但是以腾讯的声望,还是有很多的资金在不断抄底,但是一旦有人开始稳定持续的减持,对股价的影响那就容易倾斜,在大股东减持之前,其实股价本就处于弱平衡之下,腾讯目前每天也是在稳定回购,回购金额约占当日成交金额的十分之一以下,目前无法看到大股东每日减持明细,因为每减持1%的股份才会发布一次减持公告,上次发布是9.8日的时候,当时持股降到了27.96%,下次公告是持股减持到27%以下的时候,即在减持9600w股,今天腾讯成交了1600w股,我没查到港股减持的规则,假设每天减持200w股,大约需要45多个交易日,上次大股东转入了1.9亿股,全部减持完大概需要100个交易日。 而且这是算术的角度看,从理性的角度看,大股东肯定想要卖个好价钱 ,不可能无脑卖出,所以股价跌得多了,卖出速度会变慢。这些股份大概率是要全部卖出的,基本上意味着未来大半年腾讯的股价基本上会承受非常大的压力,如果你不知道什么叫压力,最近一个月的走势就是压力。 大股东的抛售金额大概率是高于每天腾讯自身回购的金额,所以你可以将这个回购行为的价值","text":"今天盘中腾讯股价再次跌2%,股价几乎创近4年新低,相比于之前跌破300港币无数人疾呼抄底,这次明显安静了很多,氛围感也没有了,毕竟上半年港股急跌以腾讯跌破300港币收尾。这次,又会怎么走? 本文仅为个人投资思考记录,不构成任何投资建议,格局不同,立场不同,仅供参考。 就在一年多以前,在全球牛市的衬托下,国内基金振臂高呼跨过香江争夺定价权,腾讯连续日内10%的涨幅拉升,股价一度接近750港币,当时的口号是1000港币不是梦,不是我在这瞎吹,我当时还买了800港币的涡轮,当时觉得突破1000不算啥事。随后没几天就开始掉转形式向下,开启了无限的下跌,绵延至今。从月线可以看出,这一路没有特别暴力的反弹。 目前腾讯股价的下跌主要几个原因,最最主要的其实是大股东的减持,港股的流动性虽然 很差,但是以腾讯的声望,还是有很多的资金在不断抄底,但是一旦有人开始稳定持续的减持,对股价的影响那就容易倾斜,在大股东减持之前,其实股价本就处于弱平衡之下,腾讯目前每天也是在稳定回购,回购金额约占当日成交金额的十分之一以下,目前无法看到大股东每日减持明细,因为每减持1%的股份才会发布一次减持公告,上次发布是9.8日的时候,当时持股降到了27.96%,下次公告是持股减持到27%以下的时候,即在减持9600w股,今天腾讯成交了1600w股,我没查到港股减持的规则,假设每天减持200w股,大约需要45多个交易日,上次大股东转入了1.9亿股,全部减持完大概需要100个交易日。 而且这是算术的角度看,从理性的角度看,大股东肯定想要卖个好价钱 ,不可能无脑卖出,所以股价跌得多了,卖出速度会变慢。这些股份大概率是要全部卖出的,基本上意味着未来大半年腾讯的股价基本上会承受非常大的压力,如果你不知道什么叫压力,最近一个月的走势就是压力。 大股东的抛售金额大概率是高于每天腾讯自身回购的金额,所以你可以将这个回购行为的价值","images":[],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/661121977","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1065,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870117527,"gmtCreate":1636593239582,"gmtModify":1636593239686,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870117527","repostId":"870133060","repostType":1,"repost":{"id":870133060,"gmtCreate":1636592186291,"gmtModify":1636592186501,"author":{"id":"3571323030005470","authorId":"3571323030005470","name":"四叶草们","avatar":"https://static.tigerbbs.com/0334c25504d77d28ac47180d08a58e9e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571323030005470","authorIdStr":"3571323030005470"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>M","listText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>M","text":"$Bank of America(BAC)$M","images":[{"img":"https://static.tigerbbs.com/491002eeaa71d5c28bf9223f78607a8a","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870133060","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":642,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870114433,"gmtCreate":1636593168460,"gmtModify":1636593168567,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870114433","repostId":"870195794","repostType":1,"repost":{"id":870195794,"gmtCreate":1636591964805,"gmtModify":1636591964888,"author":{"id":"3585607107146910","authorId":"3585607107146910","name":"10f6ccb4","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585607107146910","authorIdStr":"3585607107146910"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>[微笑] ","listText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>[微笑] ","text":"$Bank of America(BAC)$[微笑]","images":[{"img":"https://static.tigerbbs.com/8e084def90af6e4ada04717b2b3551f0","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870195794","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1584,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":839025059,"gmtCreate":1629109165371,"gmtModify":1633687350961,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/839025059","repostId":"2159248377","repostType":4,"isVote":1,"tweetType":1,"viewCount":258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897615623,"gmtCreate":1628911932562,"gmtModify":1633688538882,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/897615623","repostId":"2159321505","repostType":4,"repost":{"id":"2159321505","pubTimestamp":1628911811,"share":"https://www.laohu8.com/m/news/2159321505?lang=&edition=full","pubTime":"2021-08-14 11:30","market":"us","language":"en","title":"Tesla seeks to reduce board members’ terms, make other changes in October shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2159321505","media":"MarketWatch","summary":"Board members would serve for two years rather than three\nTesla CEO Elon Musk in Germany last year. ","content":"<p>Board members would serve for two years rather than three</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/abc701f141f0c0044cabe912e510fe2e\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Tesla CEO Elon Musk in Germany last year. MAJA HITIJ/GETTY IMAGES</span></p>\n<p>Tesla Inc. set its shareholder meeting for Oct. 7 at the Fremont, Calif., factory, with a call for reducing its directors’ terms among the proposals the electric-car maker will bring to the table, the company said in filing late Friday.</p>\n<p>One of the proposals calls for each director’s term to be reduced from three years to two years. Tesla’s board currently has nine members who are divided into three classes in staggered three-year terms.</p>\n<p>If the proposal is approved, however, the board will be divided into two classes with staggered two-year terms, with directors distributed as equally between the classes as possible, Tesla said in the filing.</p>\n<p>The board would be reduced to eight members, since Antonio Gracias, a venture capitalist who has served on the Tesla board since 2007, said in 2019 he’d not be seeking reelection when his term ends this year.</p>\n<p>Tesla’s board nominated current board members James Murdoch, the youngest son of News Corp founder Rupert Murdoch, and Kimbal Musk, Chief Executive Elon Musk’s brother, for re-election as class II directors, with terms expiring in 2024. If the term reduction is approved, then their terms would end in 2023, the company said.</p>\n<p>Tesla’s curtailing board member terms was a response to a shareholder proposal calling to elect each board member for one year.</p>\n<p>The two-year term, however, “strikes a suitable balance to the long-term interests of and nearer-term accountability to our stockholders at this time,” Tesla said.</p>\n<p>Tesla shares were flat in after-hours trading after ending the regular trading day down 0.7%. The stock has gained 1.6% this year, compared with gains of around 19% for the S&P 500 index.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla seeks to reduce board members’ terms, make other changes in October shareholder meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla seeks to reduce board members’ terms, make other changes in October shareholder meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-14 11:30 GMT+8 <a href=https://www.marketwatch.com/story/tesla-seeks-to-reduce-board-terms-in-october-shareholder-meeting-11628888340?mod=newsviewer_click><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Board members would serve for two years rather than three\nTesla CEO Elon Musk in Germany last year. MAJA HITIJ/GETTY IMAGES\nTesla Inc. set its shareholder meeting for Oct. 7 at the Fremont, Calif., ...</p>\n\n<a href=\"https://www.marketwatch.com/story/tesla-seeks-to-reduce-board-terms-in-october-shareholder-meeting-11628888340?mod=newsviewer_click\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.marketwatch.com/story/tesla-seeks-to-reduce-board-terms-in-october-shareholder-meeting-11628888340?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159321505","content_text":"Board members would serve for two years rather than three\nTesla CEO Elon Musk in Germany last year. MAJA HITIJ/GETTY IMAGES\nTesla Inc. set its shareholder meeting for Oct. 7 at the Fremont, Calif., factory, with a call for reducing its directors’ terms among the proposals the electric-car maker will bring to the table, the company said in filing late Friday.\nOne of the proposals calls for each director’s term to be reduced from three years to two years. Tesla’s board currently has nine members who are divided into three classes in staggered three-year terms.\nIf the proposal is approved, however, the board will be divided into two classes with staggered two-year terms, with directors distributed as equally between the classes as possible, Tesla said in the filing.\nThe board would be reduced to eight members, since Antonio Gracias, a venture capitalist who has served on the Tesla board since 2007, said in 2019 he’d not be seeking reelection when his term ends this year.\nTesla’s board nominated current board members James Murdoch, the youngest son of News Corp founder Rupert Murdoch, and Kimbal Musk, Chief Executive Elon Musk’s brother, for re-election as class II directors, with terms expiring in 2024. If the term reduction is approved, then their terms would end in 2023, the company said.\nTesla’s curtailing board member terms was a response to a shareholder proposal calling to elect each board member for one year.\nThe two-year term, however, “strikes a suitable balance to the long-term interests of and nearer-term accountability to our stockholders at this time,” Tesla said.\nTesla shares were flat in after-hours trading after ending the regular trading day down 0.7%. The stock has gained 1.6% this year, compared with gains of around 19% for the S&P 500 index.","news_type":1},"isVote":1,"tweetType":1,"viewCount":230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894463697,"gmtCreate":1628848657319,"gmtModify":1633689023356,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"等等","listText":"等等","text":"等等","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/894463697","repostId":"2159296424","repostType":4,"isVote":1,"tweetType":1,"viewCount":747,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":894033074,"gmtCreate":1628777028198,"gmtModify":1633689581594,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/894033074","repostId":"2158325931","repostType":4,"repost":{"id":"2158325931","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628776169,"share":"https://www.laohu8.com/m/news/2158325931?lang=&edition=full","pubTime":"2021-08-12 21:49","market":"us","language":"en","title":"BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster","url":"https://stock-news.laohu8.com/highlight/detail?id=2158325931","media":"Tiger Newspress","summary":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previo","content":"<p>BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p>\n<p><img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p>\n<p>BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p>\n<p>The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p>\n<p>There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p>\n<p>BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p>\n<p>The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p>\n<p>Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-12 21:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p>\n<p><img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p>\n<p>BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p>\n<p>The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p>\n<p>There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p>\n<p>BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p>\n<p>The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p>\n<p>Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158325931","content_text":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.\n\nBioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.\nThe WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.\nThere is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.\nBioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.\nThe conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.\nPfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.","news_type":1},"isVote":1,"tweetType":1,"viewCount":165,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":897615623,"gmtCreate":1628911932562,"gmtModify":1633688538882,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/897615623","repostId":"2159321505","repostType":4,"repost":{"id":"2159321505","pubTimestamp":1628911811,"share":"https://www.laohu8.com/m/news/2159321505?lang=&edition=full","pubTime":"2021-08-14 11:30","market":"us","language":"en","title":"Tesla seeks to reduce board members’ terms, make other changes in October shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2159321505","media":"MarketWatch","summary":"Board members would serve for two years rather than three\nTesla CEO Elon Musk in Germany last year. ","content":"<p>Board members would serve for two years rather than three</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/abc701f141f0c0044cabe912e510fe2e\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Tesla CEO Elon Musk in Germany last year. MAJA HITIJ/GETTY IMAGES</span></p>\n<p>Tesla Inc. set its shareholder meeting for Oct. 7 at the Fremont, Calif., factory, with a call for reducing its directors’ terms among the proposals the electric-car maker will bring to the table, the company said in filing late Friday.</p>\n<p>One of the proposals calls for each director’s term to be reduced from three years to two years. Tesla’s board currently has nine members who are divided into three classes in staggered three-year terms.</p>\n<p>If the proposal is approved, however, the board will be divided into two classes with staggered two-year terms, with directors distributed as equally between the classes as possible, Tesla said in the filing.</p>\n<p>The board would be reduced to eight members, since Antonio Gracias, a venture capitalist who has served on the Tesla board since 2007, said in 2019 he’d not be seeking reelection when his term ends this year.</p>\n<p>Tesla’s board nominated current board members James Murdoch, the youngest son of News Corp founder Rupert Murdoch, and Kimbal Musk, Chief Executive Elon Musk’s brother, for re-election as class II directors, with terms expiring in 2024. If the term reduction is approved, then their terms would end in 2023, the company said.</p>\n<p>Tesla’s curtailing board member terms was a response to a shareholder proposal calling to elect each board member for one year.</p>\n<p>The two-year term, however, “strikes a suitable balance to the long-term interests of and nearer-term accountability to our stockholders at this time,” Tesla said.</p>\n<p>Tesla shares were flat in after-hours trading after ending the regular trading day down 0.7%. The stock has gained 1.6% this year, compared with gains of around 19% for the S&P 500 index.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla seeks to reduce board members’ terms, make other changes in October shareholder meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla seeks to reduce board members’ terms, make other changes in October shareholder meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-14 11:30 GMT+8 <a href=https://www.marketwatch.com/story/tesla-seeks-to-reduce-board-terms-in-october-shareholder-meeting-11628888340?mod=newsviewer_click><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Board members would serve for two years rather than three\nTesla CEO Elon Musk in Germany last year. MAJA HITIJ/GETTY IMAGES\nTesla Inc. set its shareholder meeting for Oct. 7 at the Fremont, Calif., ...</p>\n\n<a href=\"https://www.marketwatch.com/story/tesla-seeks-to-reduce-board-terms-in-october-shareholder-meeting-11628888340?mod=newsviewer_click\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.marketwatch.com/story/tesla-seeks-to-reduce-board-terms-in-october-shareholder-meeting-11628888340?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159321505","content_text":"Board members would serve for two years rather than three\nTesla CEO Elon Musk in Germany last year. MAJA HITIJ/GETTY IMAGES\nTesla Inc. set its shareholder meeting for Oct. 7 at the Fremont, Calif., factory, with a call for reducing its directors’ terms among the proposals the electric-car maker will bring to the table, the company said in filing late Friday.\nOne of the proposals calls for each director’s term to be reduced from three years to two years. Tesla’s board currently has nine members who are divided into three classes in staggered three-year terms.\nIf the proposal is approved, however, the board will be divided into two classes with staggered two-year terms, with directors distributed as equally between the classes as possible, Tesla said in the filing.\nThe board would be reduced to eight members, since Antonio Gracias, a venture capitalist who has served on the Tesla board since 2007, said in 2019 he’d not be seeking reelection when his term ends this year.\nTesla’s board nominated current board members James Murdoch, the youngest son of News Corp founder Rupert Murdoch, and Kimbal Musk, Chief Executive Elon Musk’s brother, for re-election as class II directors, with terms expiring in 2024. If the term reduction is approved, then their terms would end in 2023, the company said.\nTesla’s curtailing board member terms was a response to a shareholder proposal calling to elect each board member for one year.\nThe two-year term, however, “strikes a suitable balance to the long-term interests of and nearer-term accountability to our stockholders at this time,” Tesla said.\nTesla shares were flat in after-hours trading after ending the regular trading day down 0.7%. The stock has gained 1.6% this year, compared with gains of around 19% for the S&P 500 index.","news_type":1},"isVote":1,"tweetType":1,"viewCount":230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":839025059,"gmtCreate":1629109165371,"gmtModify":1633687350961,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/839025059","repostId":"2159248377","repostType":4,"isVote":1,"tweetType":1,"viewCount":258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894033074,"gmtCreate":1628777028198,"gmtModify":1633689581594,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/894033074","repostId":"2158325931","repostType":4,"repost":{"id":"2158325931","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628776169,"share":"https://www.laohu8.com/m/news/2158325931?lang=&edition=full","pubTime":"2021-08-12 21:49","market":"us","language":"en","title":"BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster","url":"https://stock-news.laohu8.com/highlight/detail?id=2158325931","media":"Tiger Newspress","summary":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previo","content":"<p>BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p>\n<p><img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p>\n<p>BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p>\n<p>The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p>\n<p>There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p>\n<p>BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p>\n<p>The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p>\n<p>Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-12 21:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p>\n<p><img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p>\n<p>BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p>\n<p>The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p>\n<p>There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p>\n<p>BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p>\n<p>The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p>\n<p>Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158325931","content_text":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.\n\nBioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.\nThe WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.\nThere is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.\nBioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.\nThe conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.\nPfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.","news_type":1},"isVote":1,"tweetType":1,"viewCount":165,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894463697,"gmtCreate":1628848657319,"gmtModify":1633689023356,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"等等","listText":"等等","text":"等等","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/894463697","repostId":"2159296424","repostType":4,"repost":{"id":"2159296424","pubTimestamp":1628847420,"share":"https://www.laohu8.com/m/news/2159296424?lang=&edition=full","pubTime":"2021-08-13 17:37","market":"sh","language":"en","title":"4 Investing Nightmares to Avoid","url":"https://stock-news.laohu8.com/highlight/detail?id=2159296424","media":"Motley Fool","summary":"These investing horror stories are quite real, but with a good plan, you can avoid them.","content":"<p>We all invest in order to make money. With a reasonable strategy and over long periods of time, the stock market has been a very powerful wealth generating tool. The key challenges, though, are that not every investing strategy is a good <a href=\"https://laohu8.com/S/AONE.U\">one</a> and the fact that the market's progress is rarely in a straight line upwards.</p>\n<p>Those challenges make it very possible for investing to wind up a nightmare, rather than a rewarding activity. Even worse, many of those problems are caused by issues that could have been avoided by investors who were better prepared. With that in mind, these four investing nightmares are ones you can work to avoid with the proper advanced planning.</p>\n<h2>No. 1: Convincing yourself you need to sell low</h2>\n<p>Newer investors are often worried about market volatility -- the very simple fact that on any given day, a stock's price may move down instead of up. Concerned about the loss of their money if the stock falls, they'll set up something known as a \"stop loss order.\" Those are orders to a broker to sell a position if the stock's price drops below a certain dollar amount or percentage.</p>\n<p>As tempting as those orders may seem on the surface, they often turn out to be very bad ideas in practice. For one thing, if a stock was worth buying at $50 a share, why is it any less worth buying at $40? If the company's fundamentals and prospects haven't changed, a lower price may actually be a good reason to buy more instead of selling.</p>\n<p>For another, if a company's stock price only <i>temporarily </i>falls below the threshold, a stop loss order can very easily turn a <i>temporary </i>drop in price into a <i>permanent </i>loss of capital. After all, if you're no longer invested, then you will not participate in any recovery that may happen.</p>\n<p>If that weren't enough, if you sell at a loss and then buy back in within 30 days, you trigger something known as a wash sale. If that happens, you lose the ability to claim the loss you generated on your taxes until you sell \"for real.\" That adds a lot of complexity to your investment tracking and potentially removes a key real benefit that could come from taking a loss.</p>\n<h2>No. 2: Being forced by your broker to sell low</h2>\n<p>Sometimes, even more experienced investors can get lured into the siren song of margin and its potential to magnify returns when things are going well. The big problem with margin is that it is very much a double-edged sword. It magnifies the downside as well as the upside. On top of that, if the market moves too aggressively against you while you're using margin, your broker can force you to close out your investments.</p>\n<p>Unfortunately, that often turns into yet another way in which short-term volatility can turn into a more permanent loss of capital. It's also one that's largely avoidable by limiting your use of margin and recognizing that your broker has the ability to change the terms of your margin agreement to make it more restrictive.</p>\n<p>You can't avoid stock market volatility while being invested in it, but you can certainly limit the amount of margin you use to avoid that risk of being forcibly sold out during a temporary low.</p>\n<h2>No. 3: Hoping long-term money will cover short-term needs</h2>\n<p>That same market volatility means that investors can't count on stocks to be priced at any given level on any given day. As a result, if you're counting on your stocks to cover your near-term costs, you're setting yourself up for a nightmare scenario. After all, your bills won't go away just because the market may be down. If your only source of money to pay those bills comes from selling your stocks, then a down market means you'll have to sell that much more to raise the same amount of cash.</p>\n<p>It's that forced sale of more shares that really turns this into a nightmare scenario. Selling more means you keep less. Keeping less gives you that much less to participate in any recovery or market rally that may happen. That means even if the market recovers, you won't see as much of those gains as you otherwise would have, which means the next time you need cash, you'd again need to sell more.</p>\n<p>It's a vicious cycle, and it's one that you can avoid by keeping money you need to spend in the near term out of stocks. In today's low interest rate environment, you won't earn a strong rate of return on that money. The trade-off is that you will at least have a much higher certainty that the specific amount of cash you need will be there for you when you need it.</p>\n<h2>No. 4: Missing out on long-term gains due to short-term fear</h2>\n<p>Those first three nightmare scenarios are very real, and they're part of what makes people nervous about investing in the stock market. The good news is that there are ways to avoid all of them and still wind up okay. This last one, however, can create much tougher problems for people over the long haul. And that's the nightmare scenario that results when people give into their market fears and never invest at all.</p>\n<p>Despite the daily volatility and the very real short-term risks, the stock market has been a tremendously strong long-term wealth generator for generations. The key challenge, though, is that you need to be invested in the market to receive those long-term returns it can generate.</p>\n<p>When all is said and done, $0 invested at <i>any </i>rate of return for <i>any </i>amount of time will still wind up as $0. Winding up in retirement with no assets, no income, and no way to cover your costs other than what little Social Security may provide can be a real nightmare with no easy way out.</p>\n<p>Fortunately, like the other nightmares on this list, this one can also be avoided. With a good long-term investing strategy, even socking away a little bit each payday toward wealth building can go a long way toward creating a substantial nest egg.</p>\n<h2>Get started now</h2>\n<p>Indeed, a long-term focus is one of the most important tools you have at your disposal when it comes to successful investing. The thing about the long term, though, is that you get less of it every day that you delay. So get started now, and maximize your chances of leaving these nightmares well behind you.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Investing Nightmares to Avoid</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Investing Nightmares to Avoid\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 17:37 GMT+8 <a href=https://www.fool.com/investing/2021/08/13/4-investing-nightmares-to-avoid/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>We all invest in order to make money. With a reasonable strategy and over long periods of time, the stock market has been a very powerful wealth generating tool. The key challenges, though, are that ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/13/4-investing-nightmares-to-avoid/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/08/13/4-investing-nightmares-to-avoid/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159296424","content_text":"We all invest in order to make money. With a reasonable strategy and over long periods of time, the stock market has been a very powerful wealth generating tool. The key challenges, though, are that not every investing strategy is a good one and the fact that the market's progress is rarely in a straight line upwards.\nThose challenges make it very possible for investing to wind up a nightmare, rather than a rewarding activity. Even worse, many of those problems are caused by issues that could have been avoided by investors who were better prepared. With that in mind, these four investing nightmares are ones you can work to avoid with the proper advanced planning.\nNo. 1: Convincing yourself you need to sell low\nNewer investors are often worried about market volatility -- the very simple fact that on any given day, a stock's price may move down instead of up. Concerned about the loss of their money if the stock falls, they'll set up something known as a \"stop loss order.\" Those are orders to a broker to sell a position if the stock's price drops below a certain dollar amount or percentage.\nAs tempting as those orders may seem on the surface, they often turn out to be very bad ideas in practice. For one thing, if a stock was worth buying at $50 a share, why is it any less worth buying at $40? If the company's fundamentals and prospects haven't changed, a lower price may actually be a good reason to buy more instead of selling.\nFor another, if a company's stock price only temporarily falls below the threshold, a stop loss order can very easily turn a temporary drop in price into a permanent loss of capital. After all, if you're no longer invested, then you will not participate in any recovery that may happen.\nIf that weren't enough, if you sell at a loss and then buy back in within 30 days, you trigger something known as a wash sale. If that happens, you lose the ability to claim the loss you generated on your taxes until you sell \"for real.\" That adds a lot of complexity to your investment tracking and potentially removes a key real benefit that could come from taking a loss.\nNo. 2: Being forced by your broker to sell low\nSometimes, even more experienced investors can get lured into the siren song of margin and its potential to magnify returns when things are going well. The big problem with margin is that it is very much a double-edged sword. It magnifies the downside as well as the upside. On top of that, if the market moves too aggressively against you while you're using margin, your broker can force you to close out your investments.\nUnfortunately, that often turns into yet another way in which short-term volatility can turn into a more permanent loss of capital. It's also one that's largely avoidable by limiting your use of margin and recognizing that your broker has the ability to change the terms of your margin agreement to make it more restrictive.\nYou can't avoid stock market volatility while being invested in it, but you can certainly limit the amount of margin you use to avoid that risk of being forcibly sold out during a temporary low.\nNo. 3: Hoping long-term money will cover short-term needs\nThat same market volatility means that investors can't count on stocks to be priced at any given level on any given day. As a result, if you're counting on your stocks to cover your near-term costs, you're setting yourself up for a nightmare scenario. After all, your bills won't go away just because the market may be down. If your only source of money to pay those bills comes from selling your stocks, then a down market means you'll have to sell that much more to raise the same amount of cash.\nIt's that forced sale of more shares that really turns this into a nightmare scenario. Selling more means you keep less. Keeping less gives you that much less to participate in any recovery or market rally that may happen. That means even if the market recovers, you won't see as much of those gains as you otherwise would have, which means the next time you need cash, you'd again need to sell more.\nIt's a vicious cycle, and it's one that you can avoid by keeping money you need to spend in the near term out of stocks. In today's low interest rate environment, you won't earn a strong rate of return on that money. The trade-off is that you will at least have a much higher certainty that the specific amount of cash you need will be there for you when you need it.\nNo. 4: Missing out on long-term gains due to short-term fear\nThose first three nightmare scenarios are very real, and they're part of what makes people nervous about investing in the stock market. The good news is that there are ways to avoid all of them and still wind up okay. This last one, however, can create much tougher problems for people over the long haul. And that's the nightmare scenario that results when people give into their market fears and never invest at all.\nDespite the daily volatility and the very real short-term risks, the stock market has been a tremendously strong long-term wealth generator for generations. The key challenge, though, is that you need to be invested in the market to receive those long-term returns it can generate.\nWhen all is said and done, $0 invested at any rate of return for any amount of time will still wind up as $0. Winding up in retirement with no assets, no income, and no way to cover your costs other than what little Social Security may provide can be a real nightmare with no easy way out.\nFortunately, like the other nightmares on this list, this one can also be avoided. With a good long-term investing strategy, even socking away a little bit each payday toward wealth building can go a long way toward creating a substantial nest egg.\nGet started now\nIndeed, a long-term focus is one of the most important tools you have at your disposal when it comes to successful investing. The thing about the long term, though, is that you get less of it every day that you delay. So get started now, and maximize your chances of leaving these nightmares well behind you.","news_type":1},"isVote":1,"tweetType":1,"viewCount":747,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870117527,"gmtCreate":1636593239582,"gmtModify":1636593239686,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870117527","repostId":"870133060","repostType":1,"repost":{"id":870133060,"gmtCreate":1636592186291,"gmtModify":1636592186501,"author":{"id":"3571323030005470","authorId":"3571323030005470","name":"四叶草们","avatar":"https://static.tigerbbs.com/0334c25504d77d28ac47180d08a58e9e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571323030005470","authorIdStr":"3571323030005470"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>M","listText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>M","text":"$Bank of America(BAC)$M","images":[{"img":"https://static.tigerbbs.com/491002eeaa71d5c28bf9223f78607a8a","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870133060","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":642,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870114433,"gmtCreate":1636593168460,"gmtModify":1636593168567,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870114433","repostId":"870195794","repostType":1,"repost":{"id":870195794,"gmtCreate":1636591964805,"gmtModify":1636591964888,"author":{"id":"3585607107146910","authorId":"3585607107146910","name":"10f6ccb4","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585607107146910","authorIdStr":"3585607107146910"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>[微笑] ","listText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>[微笑] ","text":"$Bank of America(BAC)$[微笑]","images":[{"img":"https://static.tigerbbs.com/8e084def90af6e4ada04717b2b3551f0","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870195794","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1584,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":661641403,"gmtCreate":1663913568603,"gmtModify":1663913571224,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"好","listText":"好","text":"好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/661641403","repostId":"661121977","repostType":1,"repost":{"id":661121977,"gmtCreate":1663773601200,"gmtModify":1663774713799,"author":{"id":"3548388348794551","authorId":"3548388348794551","name":"问就是加仓up","avatar":"https://static.tigerbbs.com/4e98ddf789d46c5627f944fc581c0fe9","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3548388348794551","authorIdStr":"3548388348794551"},"themes":[],"title":"写在腾讯股价创近四年新低之际","htmlText":"今天盘中腾讯股价再次跌2%,股价几乎创近4年新低,相比于之前跌破300港币无数人疾呼抄底,这次明显安静了很多,氛围感也没有了,毕竟上半年港股急跌以腾讯跌破300港币收尾。这次,又会怎么走? 本文仅为个人投资思考记录,不构成任何投资建议,格局不同,立场不同,仅供参考。 就在一年多以前,在全球牛市的衬托下,国内基金振臂高呼跨过香江争夺定价权,腾讯连续日内10%的涨幅拉升,股价一度接近750港币,当时的口号是1000港币不是梦,不是我在这瞎吹,我当时还买了800港币的涡轮,当时觉得突破1000不算啥事。随后没几天就开始掉转形式向下,开启了无限的下跌,绵延至今。从月线可以看出,这一路没有特别暴力的反弹。 目前腾讯股价的下跌主要几个原因,最最主要的其实是大股东的减持,港股的流动性虽然 很差,但是以腾讯的声望,还是有很多的资金在不断抄底,但是一旦有人开始稳定持续的减持,对股价的影响那就容易倾斜,在大股东减持之前,其实股价本就处于弱平衡之下,腾讯目前每天也是在稳定回购,回购金额约占当日成交金额的十分之一以下,目前无法看到大股东每日减持明细,因为每减持1%的股份才会发布一次减持公告,上次发布是9.8日的时候,当时持股降到了27.96%,下次公告是持股减持到27%以下的时候,即在减持9600w股,今天腾讯成交了1600w股,我没查到港股减持的规则,假设每天减持200w股,大约需要45多个交易日,上次大股东转入了1.9亿股,全部减持完大概需要100个交易日。 而且这是算术的角度看,从理性的角度看,大股东肯定想要卖个好价钱 ,不可能无脑卖出,所以股价跌得多了,卖出速度会变慢。这些股份大概率是要全部卖出的,基本上意味着未来大半年腾讯的股价基本上会承受非常大的压力,如果你不知道什么叫压力,最近一个月的走势就是压力。 大股东的抛售金额大概率是高于每天腾讯自身回购的金额,所以你可以将这个回购行为的价值","listText":"今天盘中腾讯股价再次跌2%,股价几乎创近4年新低,相比于之前跌破300港币无数人疾呼抄底,这次明显安静了很多,氛围感也没有了,毕竟上半年港股急跌以腾讯跌破300港币收尾。这次,又会怎么走? 本文仅为个人投资思考记录,不构成任何投资建议,格局不同,立场不同,仅供参考。 就在一年多以前,在全球牛市的衬托下,国内基金振臂高呼跨过香江争夺定价权,腾讯连续日内10%的涨幅拉升,股价一度接近750港币,当时的口号是1000港币不是梦,不是我在这瞎吹,我当时还买了800港币的涡轮,当时觉得突破1000不算啥事。随后没几天就开始掉转形式向下,开启了无限的下跌,绵延至今。从月线可以看出,这一路没有特别暴力的反弹。 目前腾讯股价的下跌主要几个原因,最最主要的其实是大股东的减持,港股的流动性虽然 很差,但是以腾讯的声望,还是有很多的资金在不断抄底,但是一旦有人开始稳定持续的减持,对股价的影响那就容易倾斜,在大股东减持之前,其实股价本就处于弱平衡之下,腾讯目前每天也是在稳定回购,回购金额约占当日成交金额的十分之一以下,目前无法看到大股东每日减持明细,因为每减持1%的股份才会发布一次减持公告,上次发布是9.8日的时候,当时持股降到了27.96%,下次公告是持股减持到27%以下的时候,即在减持9600w股,今天腾讯成交了1600w股,我没查到港股减持的规则,假设每天减持200w股,大约需要45多个交易日,上次大股东转入了1.9亿股,全部减持完大概需要100个交易日。 而且这是算术的角度看,从理性的角度看,大股东肯定想要卖个好价钱 ,不可能无脑卖出,所以股价跌得多了,卖出速度会变慢。这些股份大概率是要全部卖出的,基本上意味着未来大半年腾讯的股价基本上会承受非常大的压力,如果你不知道什么叫压力,最近一个月的走势就是压力。 大股东的抛售金额大概率是高于每天腾讯自身回购的金额,所以你可以将这个回购行为的价值","text":"今天盘中腾讯股价再次跌2%,股价几乎创近4年新低,相比于之前跌破300港币无数人疾呼抄底,这次明显安静了很多,氛围感也没有了,毕竟上半年港股急跌以腾讯跌破300港币收尾。这次,又会怎么走? 本文仅为个人投资思考记录,不构成任何投资建议,格局不同,立场不同,仅供参考。 就在一年多以前,在全球牛市的衬托下,国内基金振臂高呼跨过香江争夺定价权,腾讯连续日内10%的涨幅拉升,股价一度接近750港币,当时的口号是1000港币不是梦,不是我在这瞎吹,我当时还买了800港币的涡轮,当时觉得突破1000不算啥事。随后没几天就开始掉转形式向下,开启了无限的下跌,绵延至今。从月线可以看出,这一路没有特别暴力的反弹。 目前腾讯股价的下跌主要几个原因,最最主要的其实是大股东的减持,港股的流动性虽然 很差,但是以腾讯的声望,还是有很多的资金在不断抄底,但是一旦有人开始稳定持续的减持,对股价的影响那就容易倾斜,在大股东减持之前,其实股价本就处于弱平衡之下,腾讯目前每天也是在稳定回购,回购金额约占当日成交金额的十分之一以下,目前无法看到大股东每日减持明细,因为每减持1%的股份才会发布一次减持公告,上次发布是9.8日的时候,当时持股降到了27.96%,下次公告是持股减持到27%以下的时候,即在减持9600w股,今天腾讯成交了1600w股,我没查到港股减持的规则,假设每天减持200w股,大约需要45多个交易日,上次大股东转入了1.9亿股,全部减持完大概需要100个交易日。 而且这是算术的角度看,从理性的角度看,大股东肯定想要卖个好价钱 ,不可能无脑卖出,所以股价跌得多了,卖出速度会变慢。这些股份大概率是要全部卖出的,基本上意味着未来大半年腾讯的股价基本上会承受非常大的压力,如果你不知道什么叫压力,最近一个月的走势就是压力。 大股东的抛售金额大概率是高于每天腾讯自身回购的金额,所以你可以将这个回购行为的价值","images":[],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/661121977","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1065,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}